CBIO FY 2019 Earnings — Crescent Biopharma, Inc. Revenue & Financial Results | Market Cap Arena

CBIOCrescent Biopharma, Inc.

$337M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$899,302

Operating Income

-$61M

Net Income

-$54M

EPS (Diluted)

$-1.34

Cash Flow

Operating Cash Flow

-$52M

Free Cash Flow

-$52M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$168M

Total Liabilities

$14M

Stockholders' Equity

$154M

Cash & Equivalents

$158M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$899,302	-$275,123	-226.9%
Operating Income	-$61M	-$52M	-19.2%
Net Income	-$54M	-$48M	-12.1%